New Drug Seems 'Game Changer' in Battle against Asthma
TEHRAN (Tasnim) - The first new asthma drug for nearly 20 years could have the power to significantly reduce the severity of the condition, researchers found.
The new drug, which has been hailed as a “game changer”, could reduce the number of people who die from the condition.
Three people die from asthma attacks every day, and according to Asthma UK, two thirds of the deaths are preventable.
But the pill, called Fevipiprant, was shown to reduce inflammation and repair the lining of the airways in a study led by the University of Leicester.
Professor Chris Brightling, senior research fellow at the institution, said, “A unique feature of this study was how it included measurements of symptoms, lung function using breathing tests, sampling of the airway wall and CT scans of the chest to give a complete picture of how the new drug works.”
“This new treatment, Fevipiprant, could likewise help to stop preventable asthma attacks, reduce hospital admissions and improve day-to-day symptoms – making it a ‘game changer’ for future treatment,” he added, according to SNAPPA Science.
